Reyon Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Reyon Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 10 020 KRW -0.89% Market Closed

Market Cap: ₩186.3B

R	Reyon Pharmaceutical Co Ltd KRX:102460	KR
	Vitaspring Biomedical Co. Ltd OTC:VSBC	US
	Tsentr Mezhdunarodnoy Torgovli PAO MOEX:WTCM	RU
	Millennium Services Group Ltd ASX:MIL	AU
C	Canstar Resources Inc OTC:CSRNF	CA
T	Trive Property Group Bhd KLSE:TRIVE	MY
G	Global Crossing Airlines Group Inc NEO:JET	US
S	Sypris Solutions Inc XBER:SJS	US

Profitability Summary

Reyon Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

24%

Sustainable 3Y Average Gross Margin

43%

Declining Gross Margin

54% > 24%

Negative Operating Margin

-24%

Negative 3Y Average Operating Margin

-6%

Declining Operating Margin

4% > -24%

Negative Net Margin

-28%

Negative 3Y Average Net Margin

-4%

Declining Net Margin

7% > -28%

Negative Free Cash Flow Margin

-6%

Negative 3Y Average Free Cash Flow Margin

-10%

Free Cash Flow Margin is Increasing

-11% > -6%

Negative ROE

-18%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

Declining ROIC

2% > -8%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.